✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals
Market Cap
₹142 Cr.
P/E
19.79

Key Ratios

Market cap
Market cap
142 Cr
PE
PE
19.79
Prom Holding
Prom Holding
50.86 %
ROE (%)
ROE (%)
10.67
ROCE (%)
ROCE (%)
21.47
Div Yield (%)
Div Yield (%)
2.70
Sales
Sales
294 Cr
OPM (%)
OPM (%)
9.90 %
Debt to Equity
Debt to Equity
2.01

About

Bal Pharma Limited, a prominent Indian Pharmaceutical Company, specializes in a wide range of … Read more
Low
78
52W Range
High
141
  • Bal Pharma
  • Tyche Inds
  • Mangalam Drugs&Org.
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up - API

Location Wise Break-Up - Formulations

Location Wise Break-Up

Operational Metrics

    Select a Metric
    • R&D as a % of Total Sales (%)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Bal Pharma Ltd. Business

    Bal Pharma Limited is a leading Indian pharmaceutical company with over 25 years of experience. They specialize in prescription drugs, generics, intravenous infusions, and have state-of-the-art manufacturing facilities across India.

    Bal Pharma major competitors are Tyche Inds, Mangalam Drugs&Org., Smruthi Organics, Lasa Supergenerics, Haleos Labs, Nectar Lifesciences, Everest Organics.
    Market Cap of Bal Pharma is ₹142 Crs.
    While the median market cap of its peers are ₹162 Crs.

    Bal Pharma seems to be less financially stable compared to its competitors.
    Altman Z score of Bal Pharma is 1.96 and is ranked 6 out of its 8 competitors.

    Company Filing

    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Jun Sep Dec
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material